Rozanna Yiang

Senior Vice President, Quality and Regulatory Affairs

Rozanna has over 21 years of global experience in life sciences with expertise in quality and regulatory strategies and drug development life-cycle processes, spanning from clinical development to product launch and commercialization. She joins Incysus from Axogen Corporation, where she was Vice President of Quality.  In that position, she established quality and regulatory compliance strategies to realize sustainable growth and achieve BLA approval. Previously, Rozanna was in the regenerative medicine, cell and gene therapy space for almost a decade holding senior leadership roles at Unum Therapeutics, Inc., and Biostage, Inc., where she helped achieve major strategic business, regulatory and technical product development milestones. She also played a key role in the establishment and qualification of a large commercial-scale GMP gene therapy manufacturing facility at uniQure in Lexington, MA. Earlier in her career, Rozanna founded BioCompass, Inc. a consulting firm specializing in program management, quality and regulatory compliance for eight years where she helped companies such as Shire HGT.  Across her career, Ms. Yaing has played key roles in the development, scale-up and/or commercialization of products including, Glybera®, VPRIV®, Replagal®, Elaprase®, Cerezyme®, Taxus® Paclitaxel-Eluting Stents, and OP-1 Putty.

Rozanna holds an MBA from the MIT Sloan School of Management and a BS in Chemistry from Boston College.